Unlock instant, AI-driven research and patent intelligence for your innovation.

New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)

A kind of heteroaryl, C1-C3 technology, applied in the field of new heteroaryl amide derivatives, can solve the problem of not showing HDAC isozyme selectivity and the like

Active Publication Date: 2020-04-21
MEDIBIOFARMA SL
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0048] Known HDAC inhibitors fail to display outstanding HDAC isoenzyme selectivity
This fact can cause serious problems in clinical settings, particularly in the treatment of diseases and conditions where prolonged drug administration is required

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
  • New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
  • New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0225] To a solution of Intermediate 5 (310 mg) in ethanol (20 ml) and ethyl acetate (35 ml) was added Pd / C (10%) (46 mg, 15% (w / w)) and the reaction was stirred under hydrogen overnight. After completion of the reaction as monitored by TLC, the reaction mixture was filtered through celite and evaporated to a residue. The residue was purified by preparative HPLC to obtain Example 1 as an off-white solid (20 mg, 10% yield).

[0226] 1 H-NMR (400MHz, DMSO-d 6 ):δ=10.25(br,s,1H),8.80(d,J=4.4Hz,1H),8.15(d,J=11.6Hz,1H),7.955(d,J=7.2Hz,2H),7.68 (d, J=8.0Hz, 1H), 7.42(t, J=7.6Hz, 2H), 7.31(m, 2H), 6.92(d, J=9.2Hz, 1H), 5.14(br,s, 2H) , 3.65 (t, J = 4.8Hz, 4H), 2.40 (t, J = 4.8Hz, 4H), 2.22 (s, 3H).

[0227] HPLC-MS: Rt 11.120m / z 389.6 (MH + ).

[0228] The following examples were synthesized using the procedure described in Scheme 6, starting from the corresponding pyridin-2-amine and nicotinic acid derivatives.

Embodiment 2

[0229] Example 2: N-(3-amino-6-phenylpyridin-2-yl)nicotinamide

[0230] 1 H-NMR (400MHz, DMSO-d 6 ):δ=10.60(s,1H),9.18(s,1H),8.77(dd,J=6.0,1.2Hz,1H),8.37(d,J=8.0Hz,1H),7.94(d,J= 7.6Hz, 2H), 7.71(d, J=8.4Hz, 1H), 7.58(m, 1H), 7.42(t, J=7.6Hz, H), 7.31(m, 2H), 5.29(br s, 2H ).

[0231] HPLC-MS: Rt 9.891m / z 291.0 (MH + ).

Embodiment 3

[0232] Example 3: N-(3-amino-6-(4-fluorophenyl)pyridin-2-yl)nicotinamide

[0233] 1 H-NMR (400MHz, DMSO-d 6)δ=10.59(s,1H),9.17(d,J=2.0Hz,1H),8.77(dd,J=6.8,1.6Hz,1H),8.37(m,1H),7.98(m,2H), 7.69 (d, J=8.4Hz, 1H), 7.58 (m, 1H), 7.26 (m, 3H), 5.29 (br, s, 2H).

[0234] HPLC-MS: Rt 10.590m / z 309.0 (MH + ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to novel heteroaryl amide derivatives of formula (I), as selective inhibitors of histone deacetylase 1 and 2 (hdac1-2), to methods for the production of same, to pharmaceutical compositions comprising these compounds, and to the use of said compounds for the production of a medicament for the treatment of pathological conditions or diseases that can be improved by means of the inhibition of the activity of histone deacetylase class I, particularly HDAC1 and HDAC2, such as cancer, neurodegenerative diseases, infectious diseases, inflammatory diseases, heart failureand cardiac hypertrophy, diabetes, polycystic kidney disease, sickle cell disease and beta-thalassemia disease, and to methods for the treatment of the diseases mentioned above.

Description

technical field [0001] The present invention relates to novel heteroarylamide derivatives as selective inhibitors of class I histone deacetylases of at least one enzyme selected from HDAC1 and HDAC2. [0002] Other objects of the present invention are to provide methods for the preparation of these compounds; pharmaceutical compositions comprising an effective amount of these compounds; compounds for the treatment of pathological conditions, disorders or diseases which can be achieved by inhibiting at least one member selected from HDAC1 and HDAC2 The activity of the enzyme histone deacetylase class I is improved, such as cancer, neurodegenerative diseases, infectious diseases, inflammatory diseases, heart failure and cardiac hypertrophy, diabetes, polycystic kidney disease, sickle cell disease and beta - Thalassemia disease. Background technique [0003] Histone deacetylases (HDACs) catalyze the removal of acetyl groups from histones (proteins that organize and regulate ch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07D401/12C07D409/14A61K31/444A61K31/496A61P35/00
CPCA61K31/444A61K31/496A61K31/506A61K45/06C07D401/12C07D401/14C07D409/14A61K2300/00
Inventor J·卡斯特罗帕洛米诺拉里亚J·卡马乔戈麦斯R·罗德里格斯伊格莱西亚斯
Owner MEDIBIOFARMA SL